Carmustine

CHEMBL513 Phase 4 Disetujui Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
214.0 g/mol
LogP
1.5
Phase
4

An alkylating chemotherapy agent belonging to the nitrosourea class that works by crosslinking DNA and disrupting RNA synthesis, killing rapidly dividing cancer cells. It is used to treat brain tumors, multiple myeloma, Hodgkin's and non-Hodgkin's lymphomas. Significant bone marrow suppression and pulmonary toxicity are important concerns during therapy.

Berat Molekul

214,0500 g/mol

LogP

1,50

TPSA

61,80 Ų

Lipinski RO5

Lulus

Area Terapeutik

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=NN(CCCl)C(=O)NCCCl

InChI

InChI=1S/C5H9Cl2N3O2/c6-1-3-8-5(11)10(9-12)4-2-7/h1-4H2,(H,8,11)

Molecular Formula

C5H9Cl2N3O2

HBD / HBA

1 / 3

Ikatan yang Dapat Dirotasi

4

Atom Berat

12

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

An alkylating chemotherapy agent belonging to the nitrosourea class that works by crosslinking DNA and disrupting RNA synthesis, killing rapidly dividing cancer cells. It is used to treat brain tumors, multiple myeloma, Hodgkin's and non-Hodgkin's lymphomas. Significant bone marrow suppression and pulmonary toxicity are important concerns during therapy.

Yes, Carmustine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL513. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 2578. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.